JFGIW
CORT icon

Johnson Financial Group Inc (Wisconsin)’s Corcept Therapeutics CORT Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-608
Closed -$19.7K – 819
2023
Q4 		$19.7K Buy
+608
New +$16.7K ﹤0.01% 555

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s CORT Position: Q1 2024 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Corcept Therapeutics (CORT) in Q1 2024, closing a stake of 608 shares — an estimated $19.7K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in CORT in Q4 2023 and held it in 1 quarter. The position peaked at $19.7K in Q4 2023. 287 funds tracked by Wall St. Rank hold CORT as of Q1 2024.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Corcept Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 608 Corcept Therapeutics shares in Q1 2024, an estimated $19.7K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Corcept Therapeutics in Q4 2023 and held it in 1 quarter.
  • Johnson Financial Group Inc (Wisconsin)'s Corcept Therapeutics position peaked at $19.7K in Q4 2023.
  • 287 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2024.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2024, filed 14 May 2024.